Sofiva Genomics Co., Ltd.(TW:6615)
NT$32.50+0.25 (+0.78%)
TW:6615
Sofiva Genomics Co., Ltd. financials statements
NT$32.50
At close:+0.25 (+0.78%)
Sofiva Genomics Co., Ltd. (6615) Financial Statements
Sofiva Genomics Co., Ltd. Financial Overview
Sofiva Genomics Co., Ltd.'s market cap is currently NT$696.39M. The company's EPS TTM is NT$0.66; its P/E ratio is 49.24; and it has a dividend yield of 0.93%. Sofiva Genomics Co., Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | NT$ 385.71M | NT$ 453.31M | NT$ 466.80M | NT$ 495.77M | NT$ 508.42M |
| Gross Profit | NT$ 99.13M | NT$ 135.66M | NT$ 129.91M | NT$ 148.99M | NT$ 176.81M |
| Operating Income | NT$ -33.74M | NT$ -3.37M | NT$ -15.88M | NT$ 48.35M | NT$ 65.29M |
| EBITDA | NT$ 7.87M | NT$ 66.34M | NT$ 27.86M | NT$ 46.58M | NT$ 77.19M |
| Net Income | NT$ -9.36M | NT$ 18.43M | NT$ 11.53M | NT$ 42.78M | NT$ 56.98M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | NT$ 124.71M | NT$ 146.18M | NT$ 140.03M | NT$ 170.96M | NT$ 245.19M |
| Total Assets | NT$ 724.35M | NT$ 768.08M | NT$ 767.14M | NT$ 807.56M | NT$ 822.30M |
| Total Debt | NT$ 35.53M | NT$ 53.38M | NT$ 63.59M | NT$ 74.67M | NT$ 90.14M |
| Net Debt | NT$ -55.08M | NT$ -58.70M | NT$ -33.22M | NT$ -45.14M | NT$ -124.85M |
| Total Liabilities | NT$ 95.91M | NT$ 123.68M | NT$ 148.77M | NT$ 180.24M | NT$ 197.86M |
| Stockholders' Equity | NT$ 628.13M | NT$ 644.04M | NT$ 618.14M | NT$ 626.92M | NT$ 624.23M |
| Cash Flow | |||||
| Free Cash Flow | NT$ 7.20M | NT$ 10.57M | NT$ -859.00K | NT$ -18.56M | NT$ 67.42M |
| Operating Cash Flow | NT$ 15.36M | NT$ 34.69M | NT$ 23.70M | NT$ 17.14M | NT$ 80.07M |
| Investing Cash Flow | NT$ -14.44M | NT$ -10.66M | NT$ -9.99M | NT$ -53.48M | NT$ -10.03M |
| Financing Cash Flow | NT$ -22.28M | NT$ -8.57M | NT$ -36.67M | NT$ -58.65M | NT$ -44.19M |
Currency in TWD
